Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/1989
06/28/1989EP0321967A2 Compounds active on the cardiovascular system
06/28/1989EP0321956A1 Amino acid imide derivatives, usage thereof, and medicinal compositions containing the same
06/28/1989EP0321940A2 An improved method for the preparation of natural human growth hormone in pure form
06/27/1989CA1338327B 1-(4'-Fluorophenyl)-3,5-Substituted Indoles Useful in the Treatment of Psychic Disorders
06/27/1989CA1256437A1 1-(4'-fluorophenyl)-3,5-substituted indoles useful in the treatment of psychic disorders
06/21/1989EP0321192A2 Non-peptidic renin inhibitors
06/21/1989EP0321128A1 Fatty acid compositions
06/21/1989EP0321100A2 Piperazine derivatives, their acid addition salts and a process for the preparation of same
06/21/1989EP0320935A2 Method of preventing or treating toxemia in pregnancy using a thromboxane A2 receptor antagonist
06/21/1989EP0320753A2 Derivatives of cyclic aminoacids, their preparation, compounds containing them, and their use
06/21/1989EP0320630A1 Enantiometric iodobenzamides
06/21/1989EP0320628A1 Substituted furan compounds which are useful in inhibiting lipoxygenase enzymes, particularly 5-lipoxygenase
06/20/1989US4841077 Isoflavone derivatives, and salts thereof, and cancerocidal and immunosuppressive agents containing the same
06/20/1989US4840970 Aqueous solution containing lipid-soluble pharmaceutical substance
06/20/1989US4840966 Administering epigallocatechin gallate, theaflavin. theaflavin mono(di)gallate
06/20/1989US4840964 For treatment of cardiovascular, nervous systems, and metabolism disorders in animals and humans
06/20/1989US4840935 Peptide amino-alcohol derivatives containing a tetrasubstituted carbon atom, inhibiting renin and acid proteases, process for obtention and therapeutical use
06/20/1989CA1256112A1 Imidazolyl, triazolyl, and tetrazolyl compounds
06/20/1989CA1256031A1 Pharmaceutical compositions containing diltiazem and alfuzosin
06/15/1989WO1989005295A1 Acyl derivatives of hydroxypyrimidines
06/14/1989EP0320267A2 Glycoprotein growth modulation materials
06/14/1989EP0320148A1 Analogs of fibroblast growth factor
06/14/1989EP0320118A2 Peptides with collagenase inhibiting activity
06/14/1989EP0319947A2 Bis-S-alkylbenzene derivatives
06/14/1989EP0319900A2 Furyl, phenylene and thienyl leukotriene B4 analogues
06/14/1989EP0319676A2 Chondroitin polysulfate compositions for the treatment of immunodeficiencies caused by retroviruses
06/14/1989CN1033379A Acyl derivatives of hydroxy pyrimidines
06/13/1989US4839387 Derivative of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it
06/13/1989US4839384 Method of inhibiting onset of or treating migraine headache using a thromboxane A2 receptor antagonist
06/13/1989US4839379 Aromatase inhibitors
06/13/1989US4839371 3-aralkyl-2-mercaptoyridines as dopamine-β-hydroxylase inhibitors
06/13/1989US4839366 Methylthioquinolyl guanidine derivative, process of preparation thereof and pharmaceutical compositions therefrom
06/13/1989US4839354 Acetic acid analgesics with antitussives, antihistamines, decongestants
06/13/1989CA1255685A1 Process for preparing 7-¬2-(dialkylamino)ethyl|-4- hydroxy-1,3-benzimidazol-2-ones
06/13/1989CA1255601A1 Method for improving the look of the scalp and hair by using a cosmetic composition containing acetyl-10 triacetoxy-1,8,9 anthracen as active ingredient
06/13/1989CA1255600A1 Pharmaceutical compositions containing acethyl-10 triacetoxy-1,8,9 anthracen as active ingredient
06/13/1989CA1255599A1 Pharmaceutical compositions containing a 1-substituted methoxy-4-trimethyl-1,2,3,6 benzene derivative
06/13/1989CA1255598A1 Pharmaceutical compositions with analgesic properties and the preparation and use thereof
06/13/1989CA1255596A1 Pharmaceutical compositions containing dihydropyridine
06/13/1989CA1255563A1 Pseudoephedrine, brompheniramine therapy
06/08/1989DE3839883A1 Pharmazeutisches praeparat Pharmaceutical of preparation
06/07/1989EP0319482A2 Novel substituted propane phosphinic acid compounds
06/07/1989EP0319479A2 Substituted propane-phosphinic acid compounds
06/07/1989EP0319463A2 Use of 4H-benzo[4,5]cyclohepta[1,2-b]thiophene derivatives to effect monokine inhibition
06/07/1989EP0319330A2 Pyrrolophthalazines
06/07/1989EP0319170A2 Acyl derivatives of hydroxy pyrimidines
06/07/1989EP0319052A2 Mutant acidic fibroblast growth factor
06/07/1989EP0318935A2 Substituted alpha-amino acids having pharmaceutical activity
06/07/1989EP0318849A2 Manumycin derivatives, process for their preparation and their use
06/07/1989EP0318801A2 Preparation to prevent adhesion of organs and organ parts
06/07/1989EP0318488A1 Stimulation of angiogenesis and promotion of endothelialisation
06/07/1989CN1033239A Joint lubricant
06/06/1989US4837379 Fibrin-collagen tissue equivalents and methods for preparation thereof
06/06/1989US4837235 Indole and indazole keto sulphones as leukotriene antagonists
06/06/1989CA1255304A1 Tetracyclic spiro-hydantoin aldose reductase inhibitors
06/01/1989WO1989004832A1 Analogs of fibroblast growth factor
06/01/1989WO1989004828A1 Cyclodextrin clathrates of 5-cyano-prostacycline derivatives and their use as drugs
06/01/1989WO1989004825A1 New derivatives of cysteine, processes for their preparation and their use
06/01/1989WO1989004660A1 5-ht3 receptor antagonists for treatment of cough and bronchoconstriction
06/01/1989WO1989004659A1 Use of melatonin or derivatives thereof for the production of pharmaceutical compositions effective to counteract the effects of aging
05/1989
05/31/1989EP0318377A2 Enantiomeric derivatives of amino acids, process for their preparation and their pharmaceutical applications
05/31/1989EP0318281A2 Use of dsRNA in the prevention of viral escape
05/31/1989EP0318234A2 Improvements in or relating to selective serotonin uptake inhibitors
05/31/1989EP0318233A2 Improvements in or relating to serotonin and norepinephrine uptake inhibitors
05/31/1989EP0318184A1 Acceleration of bone formation with GM-CSF
05/31/1989EP0318093A2 Diarylquinoline diacids and their use as medicaments
05/31/1989EP0318091A2 Resolved amino pyrrolidine neuroprotective agents
05/31/1989EP0318084A2 Benzoheterazoles
05/31/1989EP0318066A1 Aryl-substituted thiophene 3-ols, derivatives and analogs, as lipoxygenase inhibitors
05/31/1989EP0317959A2 Anti-ulcer composition
05/31/1989EP0317956A2 Anti-tumor prodrugs
05/31/1989EP0317878A1 Stabilized pharmaceutical agents, process for preparing them, and stable pharmaceutical preparations
05/31/1989EP0130142B1 Prostacycline derivatives, process for their preparation and their use as medicines
05/31/1989CN1033182A Antiparkinson ergoline derivatives
05/30/1989US4835189 Phenolic thioalkylamides as inhibitors of 5-lipoxygenase
05/30/1989US4835184 Novel pharmaceutical compositions intended to the treatment of neuropathies and promoting the nervous regeneration
05/30/1989US4835174 Pilocarpine derivatives
05/30/1989US4835154 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors
05/30/1989CA1254889A1 Cosmetic compositions containing 1,8-dihydroxy-10- phenyl-9-anthrone as an active ingredient; application thereof and process for preparing the active ingredient
05/30/1989CA1254832A1 Interferon administration vehicles
05/24/1989EP0317540A1 Cysteine derivatives, processes for their preparation and their use
05/24/1989EP0317269A2 Antiparkinson ergoline derivatives
05/24/1989EP0317165A1 DI-t-butylphenols substituted by an alkoxy or benzyloxy group or a benzylthio group
05/24/1989EP0316967A1 Fluorine-containing nitroimidazole derivatives and radiosensitizer comprising the same
05/24/1989EP0316907A2 Enzyme inhibitor and method of producing the same
05/24/1989EP0316633A1 Medicine containing azelastine for application in the nose and/or at the eye
05/24/1989CN1033044A Butenoic acid amide compounds, their salts, pharmaceutical composition containing same, and process for preparing same
05/24/1989CN1033043A Autidepressants
05/23/1989US4833259 Light screening agents
05/23/1989US4833258 Intermediates useful in the preparation of HMG-COA reductase inhibitors
05/23/1989US4833144 2-Alkylsulfinyl-4(3H)-quinazolinone derivatives and pharmaceutical compositions
05/23/1989CA1254700A1 Process for preparing biologically active heptapeptides
05/23/1989CA1254699A1 Renin inhibitors containing statine or derivatives thereof
05/23/1989CA1254566A1 Intermediate products, processes for the preparation thereof and the use thereof
05/23/1989CA1254565A1 Process for preparing norscopine
05/23/1989CA1254564A1 Quaternary 6,11-dihydro-dibenzo-[b,e]-thiepine-11- n-alkyl-norscopine ethers and processes for preparing them
05/23/1989CA1254559A1 Class of spiro-linked pyrrolidine-2,5-diones and preparations thereof
05/23/1989CA1254557A1 (2-oxo-1,2,3,5-tetrahydroimidazo-(2,1-b) quinazolinyl) oxyalkylamides
05/23/1989CA1254517A1 Pharmaceutical compositions containing 1,8-dihydroxy-10-phenyl-9-anthrone as an active ingredient
05/18/1989WO1989004325A1 Neutrophil-activating polypeptide, process for its manufacture and its use as a drug and diagnosticum
1 ... 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 ... 1564